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ABSTRACT
Fifty-four naive, male, hooded rats were given a mild 
electric shock after stepping down from a small wooden plat­
form. After this single trial, no animal was tested for 2 
days. On the fourth day, all animals were returned to the 
platform and their step-down latencies recorded. Animals 
were injected with melanocyte-stimulating hormone (MSH), an 
MSH-release inhibiting factor (MIF), or saline on acquisition 
day only, on extinction day only, on both acquisition and 
extinction day, or on all 4 days. The data showed that re­
gardless of when MSH was injected, it resulted in increased 
resistance to extinction as evidenced by greater inhibitory 
performance when compared with rats injected with either MIF 
or saline. The results obtained with this modified procedure 
confirm that MSH produces Increased resistance to extinction 
and extend these findings to a pigmented strain of rats. A 
second study was performed to determine specific behavioral 
effects for various dosages of both MSH and MIF. The pro­
cedure for this study was the same as above except all sub­
jects were injected once daily for four days.
vi
INTRODUCTION
The endocrine glands manufacture hormones which are 
essential for normal physiological and psychological func­
tioning. Consequently, underactivity or overactivity of the 
endocrine glands may markedly affect psychological function­
ing, in addition to lowering general stress tolerance 
(Coleman, 1972). Awareness of such facts contained in the 
above statements has been no secret. Indeed, many of the 
symptoms related to endocrine dysfunctions and diseases have 
been known since antiquity. For example, swelling of the neck 
(called goiter), the sweet-tasting urine of diabetes mellitus, 
and perhaps menstrual disorders have been recognized for thou­
sands of years.
Similarly, ancient Egypt recognized the relationship 
between the external sexual organs of the woman and the onset 
of pregnancy and advocated the use of contraceptives. During 
the Vedic period in India (100 B.C.) the practice of obste­
trics was widespread, and the practioners were also familiar 
with such facts as causes and duration of pregnancy (Brown 
and Barker, 1966). Such statements, however, are only 
slightly more sophisticated than the primitive traditions of 
eating certain tissues to obtain their characteristic func­
tions, such as the brain for intelligence, the heart for
2courage, and the reporductive organs for fertility, but they 
do indicate an awareness of the effects of internal bodily 
secretions on behavior.
Rolleston (1936) has emphasized the year 1855 as the 
turning point in the history of endocrinology. It was in 
that year that Claude Bernard first used the term "internal 
secretion" in conjunction with hepatic production of blood 
sugar, as contrasted with the external secretion of bile.
In that same year, Thomas Addison issued his treatise on dis­
ease of the suprarenal capsules. But perhaps most of all, 
it has been the pituitary gland, or hypophysis, that has at­
tracted the attention of many scientists since the time of 
Galen, and several functions have been attributed to it. It 
was not until 1555 that Versalius suggested that the peculiar 
gland served as a funnel to withdraw phlegm from the brain.
In fact, the word pituitary means "mucous." Despite its long 
history it was not until 1895 that Schaefer and Oliver des­
cribed some of the secretory properties of this organ. In 
addition, the anterior pituitary Is so important as an endo­
crine organ that it has been called the "master" gland of the 
body, Primarily because of its influence upon many of the 
other endocrine organs.
The pituitary is located In a cavity of the sphenoid 
bone, the sella turcica, below the base of the brain. It 
is attached to the brain proper by means of a stalk, the
3infundibulum. The gland is a reddish-gray mass weighing 
about 0.5g in the human being (Brown and Barker, 1966) and is 
generally divided into three parts, the anterior lobe or adeno­
hypophysis (the secretory lobe), the intermediate lobe, and 
the posterior lobe or neurohypophysis.
The blood supply to the hypophysis is extensive and 
arises from the hypophysial arteries which are branches of 
the carotids. These branches form an extensive capillary net­
work upwards into the hypothalamus and downward into the gland 
proper. This means that the gland obtains blood directly 
from the arterial system and secondly from a hypothalamico- 
hypophysial portal system. The dual supply has important 
consequences on the activity of the gland. The two major di­
visions of the pituitary, the anterior and posterior lobes, 
have separate blood supplies and insofar as can be determined 
are not related functionally to each other. There is little 
indication of important innervation of the anterior pituitary 
although some nerves have been demonstrated by staining. The 
posterior pituitary, however, is almost entirely nervous tis­
sue .
Until recently, very little attention has been given 
to the intermediate lobe of the pituitary. In most animals 
this lobe is almost indistinguishable from the anterior lobe 
and is usually separated with it on dissection. Its function, 
therefore, cannot truly be evaluated (Brown and Barker, 1966).
4It is the intermediate lobe of the pituitary of many species 
that secretes a hormone which is capable of dispersing the 
melanocytes of the skin to produce a characteristic darkening. 
Because of this peculiar property, the hormone has been called 
melanocyte-stimulating hormone (MSH), chromatophore hormone 
(CH), intermedin or intermediate lobe hormone (IH).
The isolation of MSH from pituitary glands of domestic 
animals was first reported by Teh Lee and Aaron Lerner in 
1956. These investigators showed that two substances possess­
ing MSH activity were present in porcine pituitary glands.
They proposed that these substances be referred to as alpha 
(ot) and beta (£)-MSH. c*-MSH consists of a sequence of thir­
teen amino acids, while y#-MSH contains eighteen amino acids 
and has less melanin-dispersisg activity than ot-MSH. Ini­
tially there was considerable uncertainty about the relation* 
ship (both structural and functional) between MSH and adreno- 
corticotrophlc hormone (ACTH) because of the difficulties 
encountered in the separation of the two hormones (Sulman, 
1952; Reinhardt, Geschwind, Forath and Li, 1952). It was 
later found that ACTH has inherent melanin-dispersing activi­
ty and a structure resembling that of the MSHs. When the 
amino acid sequence was determined for oC-MSH, it was found to 
be the same as that of the first thirteen amino acids found 
in ACTH (Harris, 1959). This similarity is demonstrated in 
the case of Addison's Disease (adrenal cortical insufficiency)
5in which excess endogenous ACTH would be expected and which 
is characterized by increased pigmentation (Coleman, 1972).
The pigmentation of Addison's disease is believed to be due 
in part to the action of the increased ACTH content of the 
blood that occurs in thifc disease and in part to y>-MSH, which 
has been demonstrated to be present in the serum. The struc­
ture of et-MSH appears to be the same in all mammalian species, 
but there are slight differences in the yf-MSHs (Novales, 1967; 
Karkun and Landgrebe, 1963). These differences usually in­
volve amino acid substitutions, but human )0-MSH is also longer 
than hog/f-MSH (Harris, 1959)*
As mentioned previously, the most widely studied effect 
of MSH on chromatophores is the ability to produce melanin 
dispersion in the melanophores of coldblooded vertebrates. A 
chromatophore is a pigment cell that is able to disperse 
or aggregate its pigment in response to appropriate stimuli. 
Melanophores are melanin-containing chromatophores. Melano­
cytes are melanin-producing and melanin-containing cells 
found in all vertebrates, but the melanin in melanocytes can­
not be dispersed or aggregated to stimuli as it can in melano­
phores. In the vertebrates, melanophores are only found in 
fishes, amphibians, and reptiles. The melanin-containing 
cells of the skin of mammals and birds are melanocytes and 
they seem to possess the ability to donate melanin to other 
cells in feathers, hairs, Pr epidermis (Novales, 1967).
6These color changes are Induced by alterations In cer­
tain cells (chromatophores) of the skin which contain pigments 
that are black or brown (melanophores), yellow (xanthaphores), 
red (erythrophores) and white (leukophores). Such alterations 
in color are produced by the condensation (to pale) or dis­
persion (to darken) of the pigment granules in the chromato- 
phores, a process which is under the control of a combination 
of nervous and chromonal factors (Grollman, 1964).
For example, the capacity of lower vertebrates to un­
dergo color changes is a function of MSH and is of vital Im­
portance to their survival. The common grass frog, for 
example, which is normally of a dull greenish hue, if placed 
in a cold, moist shaded place becomes dusky within a few 
hours and intensely black after several days. Similarly, it 
pales If placed in a damp, warm, lighted place.
According to Grollman (1947) the chromatophoric re­
sponse is brought about by a number of stimuli (humidity, 
temperature, oxygen supply, illumination, etc.) acting on 
the retina or other receptors. In addition, the color of 
the response is determined by the Intensity of the illumina­
tion which can be modified by the character of the back­
ground. Certain fishes, e.g., Gastrosteres aculeatus (the 
stickleback), Rhodeus amarus (the bitterling), and the 
Phoxinus laevis (carp-like) also develop a brillant red 
color on the ventral part of the body at the time of spawning.
7This "wedding dress" is most pronounced in the male and is 
due to the formation of new pigment-containing cells. Injec­
tion of hypophyseal extracts induces dispersion of the ery- 
throsomes in these fishes, and the substance responsible for 
the reaction is thought to be MSH (Zondek, 1935).
The darkening of the skin during pregnancy is also 
accompanied by an increased MSH-activity of the blood and the 
urine. Whether this represents MSH or ACTH or other compounds 
secreted by the pituitary or the placenta has not been estab­
lished (Grollman, 1964). Similarly, Lerner, Shizume, and 
Bunding (1954) found that natural MSH with no appreciable 
ACTH activity produces a darkening of human skin and nevi 
(growth of the skin) similar to that seen in patients with 
adrenal insufficiency. Similar results were obtained with 
synthetic oC-MSH by McGuire and Lerner (1963).
The physiologic mechanism involved in the "pigmentary 
effector system" is diverse. It appears that epinepherine 
exerts a melanophore expanding action, and in the reptiles, 
the adrenals appear to be the important organs regulating 
pigmentation. The exact mechanism of the effect has not yet 
been clarified, but it presumably involves increased melanin 
synthesis in the melanocytes, followed by passage of melanin 
into overlying epidermal cells. In the guinea pig, in addi­
tion to increasing the number of melanocytes and amount of 
melanin in the abdominal wall, /0-MSH Increases the length,
8width and complexity of the dendritic processes of the melano­
cytes (Snell, 1962). Finally, it should be pointed out that 
MSH increases the melanin content of hamster melanoma (Foster, 
1959).
Although the most common effects of MSH have been re­
lated to pigmentary changes, a number of extra-chromatophoral 
effects have been described that are comparable to the extra­
adrenal effects of ACTH (Engel, 1961). As mentioned previous­
ly, some of these effects are shared with ACTH and appear to 
be the result of common amino acid sequences. MSH is also 
closely related to o<-corticotropin-releasing factor («c-CRF), 
although not necessarily identical to it (Schally, Anderson, 
Lipscomb, Long and Guilleman, i9 6 0). Various aspects of the 
complex problem posed by CRF have recently been reviewed by 
Hofmann (1962) and Schwyzer (196A). It has also been sug­
gested that ot-MSH may serve as a precursor for ACTH in the an­
terior pituitary (Novales, 1967). This appears to be a 
reasonable possibility in view of the identity of the first 
thirteen amino acids in the two hormones. As to ACTH activi­
ty per se, «C-MSH has many of the properties of ACTH in vitro 
(Steelman and Guillemin, 1959)f although it is inactive in 
vivo (Hofmann, 1962). In addition, the MSHs have an adipo- 
kenetic effect (mobilization of fat in the body) as does ACTH. 
Dempsey (1972) has observed apparent weight losses for animals 
treated with MSH despite the fact that the quantity of their
9food intake is not affected (unpublished data).
In addition, a variety of other effects of the MSHs 
are known. Several of these are on the nervous system itself, 
and thus of great potential interest to psychology and neuro­
endocrinology. For example, Ferrari and co-workers have found 
that injection of MSH or ACTH into the cisterna magna of dogs 
produces muscular hypertonus (stretching). A number of other 
hormones and drugs are ineffective in this regard. Ferrari, 
Gessa and Vargui (1963) reviewed this work and reported on 
the inability of melatonin to antagonize the stretching re­
sponse to MSH, even at high doses. This result suggests that 
there are differences in the receptors for melanophore stimu­
lation and the stretching effect. The effect is not due to 
a contaminant since a synthetic peptide related to MSH is 
also effective. It may have some relation to the regulation 
of sleeping and yawning behavior of which little is known 
from an endocrine point of view. An effect on the electrical 
activity of neurons was first reported by Guillemin and 
Krivoy in i960 and later reviewed by Krivoy, Lane and Kroeger 
in 1963. These investigators reported that injections of 
^-MSH in cats increased the amplitude of spinal monosynaptic 
reflex potentials. Other hormones, e.g., o<-MSH, ACTH, oxy­
tocin, or vasopressin, are ineffective in this regard. These 
results were viewed as a clue that ot-MSH may function as a 
neurohumor in mammals. This hypothesis received support from
10
the finding that brain extracts produce an enzymic inactiva­
tion of /f-MSH. Liver or muscle extracts are ineffective . 
Chlorpromazine was reported to reversibly antagonize the 
effect ofy5-MSH on the positive intermediary potential in the 
cat spinal cord. It was concluded that chlorpromazine may 
act to lower the central excitatory state of the nervous 
system by modifying the action ft-MSH. These results all de­
monstrated that/T-MSH facilitates submaximally induced spinal 
reflexes in the cat, but did not reveal any modification of 
behavior associated with the effect. Krivoy et al. (1963) 
also noted that placing ^ -MSH in the aquarium water reduced 
the frequency of change of amplitude in the spontaneous dis­
charge of the transparent knife fish, Gymnotidae eigenmannia, 
indicating a possible effect on the excitability of the nervous 
system of this fish. Krivoy et al. (1963) discusses these 
results in the light of the possibility that /J-MSH and cer­
tain other peptides are neurohumors. If correct, this view 
would require production of ^ -MSH by neurons, and this is 
clearly different from the possibility that pituitary yff-MSH 
affects nervous function.
Optical effects have also been described. To date, 
conflicting results have been obtained on dark adaptation. 
Hanaoka (1951) followed up earlier work and reported that 
MSH shortens the time required for dark adaptation in man.
On the other hand, Kalant, Ogilvie, Smith, Taylor and Walker
11
(1959) failed to confirm this work in a careful study using 
MSH prepared in a manner similar to that used by Hanaoka. 
Hanaoka (1953) also reported that MSH enhances the regenera­
tion of bleached visual purple extracted from amphibian eyes, 
but this work has not been repeated with pure hormones.
Another visual effect has recently been described by Dyster- 
Aas and Krakau (1964J. They found that both MSHs and other 
related peptides are able to produce an "aqueous flare re­
sponse" in the rabbit eye when administered systemically.
Since the aqueous flare response is due to the presence of 
macromolecules in the aqueous humor, this may be evidence 
that MSH increases the permeability of the blood-aqueous 
humor barrier in the eye. The effect was correlated with the 
melanin-dispersing activity of the hormones and was elicited 
more readily in pigmented that in albino animals (Martini 
and Ganong, 1967).
Not only has MSH been shown to have various physiologi­
cal effects, but more recently there is a body of data which 
suggests that it, like ACTH, may also have behavioral or psy­
chological effects as well. Because of their structural simi­
larity, behavioral findings with both MSH and ACTH will be 
reviewed. The fir6t demonstration of the effects of the pi­
tuitary-adrenal system on learned behavior was presented by 
Mirsky, Miller and Stein in 1953. Then in 1955* Murphy 
and Miller reported that ACTH delayed extinction of an active
12
avoidance response, and subsequently Miller and Ogawa (1962) 
showed that ACTH administered during avoidance learning had 
a similar effect in adrenalectomized animals. This led them 
to the conclusion that the adrenals themselves appeared not 
to play a significant role in the maintenance of a conditioned 
avoidance response.
In a similar study, Engel (1961) reported that the 
acquisition of an avoidance response in the rat was not af­
fected by ACTH in either adrenalectomized or intact animals. 
Again it appeared that the adrenals themselves apparently, did 
not play a significant role in avoidance behavior since total 
adrenalectomy did not alter the course of acquisition or 
extinction. These results also suggested that ACTH has signi­
ficant behavioral effects apart from its trophic action on 
the adrenal cortex. While the mechanism responsible for this 
extra-adrenal action of ACTH is unknown, Engel suggested that 
it may be related to a variety of metabolic effects of ACTH 
which apparently are also not mediated by the adrenal cortex.
In many of the studies concerning the effects of ACTH 
on behavior, it is not quite clear whether the obtained 
effects are due to the direct action of ACTH on the nervous 
system or rather to corticosteroids which have been secreted 
following stimulation of the adrenals by ACTH. This is par­
ticularly confusing as ACTH and corticosteroids are reported 
to exhibit an opposite effect on extinction of conditioned
13
avoidance behavior, while glucocorticosteroids can facilitate 
the rate of extinction (Miller and Ogawa, 1962; DeWied, 1967; 
Weiss, McEwen, Silva and Kalkut, 1969; Van Wimersma Greldanus, 
1970). Interference by adrenocortical steroid action in some 
studies is minimized or excluded by administering low doses 
of ACTH in a long-acting preparation or by using adrenalecto­
mized animals.
The study of the effects of ACTH on the behavior of 
intact animals received a new impetus after the discovery 
that fragments of this hormone containing the first 10 amino 
acids, or even smaller peptides like ACTH-(4-10) could still 
exhibit a similar behavioral effect as ACTH. These peptides 
lack the well-known biological activities of the intact 
hormone such as stimulation of the adrenals. With such a 
discovery the behavioral effect of ACTH could now be studied 
in intact animals independently of concomitant steroid action 
(DeWied, 1966; Greven and DeWied, 1967)•
The labeling of these and related peptides as "ACTH- 
analogues" is described by Wejnem-Slangen (1970) as more a 
matter of habit than of precise description since both vi­
and yff-MSH, which exert a similar inhibiting effect on extinc­
tion of conditioned avoidance behavior as ACTH, share the 
a&ino acid sequence that is conveniently, if not accurately 
referred to as ACTH-(4-10).
As one might predict, hypophysectomized animals are
lb
deficient in the acquisition of a conditioned avoidance re­
sponse. DeWied (1970) has reported that the deficiency in 
acquisition in hypophysectomized animals is ameliorated when 
the animal is given ACTH-replacement therapy. In addition 
to the naturally occurring ACTH molecule, ACTH-1-10 and ot-MSH 
can also influence the acquisition of the conditioned avoid­
ance response in hypophysectomized animals. Similarly, Gispen, 
Van Wimersma Greidaners and DeWied (1970) have reported that 
the threshold for the response to inescapable electric shock 
was lower in hypophysectomized rats than in intact animals. 
However, treatment with ACTH and ACTH-1-10 failed to affect 
the thresholds in either hypophysectomized or intact rats.
It was concluded that the stimulating effect of ACTH and ACTH 
analogues on conditioned avoidance acquisition in hypophy­
sectomized animals is not the result of an influence on sen­
sory capacities, Inasmuch as the pain thresholds for electric 
shock were not changed by these peptides but the learning 
capacity is markedly enhanced.
The role of ACTH in the acquisition of an avoidance 
response has also been investigated by Beatty, Beatty, Baulman, 
and Gilchrist (1970). Using intact animals they found that 
ACTH did not facilitate the acquisition of an avoidance re­
sponse when the electric shock intensity was high. Facili­
tation, however, was observed when the intensity of the un­
conditioned stimulus was moderate. These investigators also
15
found that acquisition of the avoidance response was facili­
tated by adrenalectomy, and they concluded that the action of 
ACTH on the acquisition of avoidance conditioning was clearly 
extra-adrena1. It should again be pointed out, however, that 
ACTH is not essential to normal performance when the inten­
sity of the fear-inducing stimulus is sufficiently high.
In an attempt to locate the possible site of action 
of glucocorticoids in the central nervousgystem, Bohus (1970) 
implanted cortisone into various brain sites and determined 
the influence of these implants on the extinction of a condi­
tioned avoidance response. The action of the corticoids in 
rats appeared to be localized to several limbic, diencephalic 
and mesencephalic regions. It was shown that implants of 
hydrocortisone into the medial thalamus, anterior hypothalamus, 
rostral septum, or amygdala all facilitated the extinction 
of a conditioned avoidance response. When ACTH was adminis­
tered to rats with hydrocortisone implants, however, it was 
able to maintain conditioned avoidance behavior if the implants 
were in the anterior hypothalamus or rostral septum. ACTH 
given to animals with medial thalamus implants had no main­
tenance effect on the conditioned avoidance response.
The involvement of the medial thalamus in the media­
tion of behavioral effects of oC-MSH and ACTH has been demon­
strated in rats with bilateral lesions in the thalamic 
parafascicular region (Bohus and DeWied, 1967). Animals
16
lesioned in the parafascicular muclei of the thalamus showed 
a facilitated rate of extinction of a conditioned avoidance 
response, but without affecting avoidance learning. Treat­
ment with long-acting oC-MSH during extinction failed to affect 
the rate of extinction. Since MSH delays extinction of avoid­
ance responding in posterior lobectomized rats in which a 
similar rapid rate of extinction is found (DeWied, 1965),
Bohus and DeWied concluded that the results stressed the im­
portance of the central nervous system (CNS) for the effect 
of OC-MSH on conditioned avoidance behavior.
The question, however, arises whether the thalamic pa­
rafascicular region is the site of action of the pituitary 
peptides (e.g., MSH) or whether higher nervous structures 
disrupted by lesions are involved. Observations in rats 
with thalamic reticular lesions suggest that certain motiva­
tional deficits might be responsible for the rapid extinction 
of the avoidance response (Bohus and DeWied, 1968). Accord­
ingly, the effects of «t-MSH might be manifested through those 
mechanisms which subserve the organization of motivational 
factors in an avoidance situation.
An interesting comment along these lines was put forth 
by Cardo and Valadi, who reported that impairments in avoid­
ance behavior of rats bearing thalamic parafascicular nuclei 
lesions can be partially normalized by the administration of 
amphetamine. It seems likely then that the failure of aC-MSH
17
to affect the rate of extinction in rats with thalamic para- 
fasicular lesions may suggest that the effect of pituitary 
peptides on avoidance behavior is of a more specific char­
acter than mere excitation of CNS activity.
In a more general study, DeWied (1965) concerned him­
self with the influence of the posterior and intermediate 
lobe of the pituitary and pituitary peptides on the main­
tenance of a conditioned avoidance response in rats. With 
posterior and intermediate lobectomy, DeWied found a facili­
tated rate of extinction of a conditioned avoidance response 
without affecting avoidance learning. If, however, pitressin, 
purified lysine vasopresson, synthetic OC-MSH and ACTH were 
administered as long acting preparations during the period of 
extinction, the rate of extinction was inhibited. These data 
indicate that presence of the posterior and/or intermediate 
lobe of the pituitary is essential for the maintenance of 
avoidance responding and that peptides representing these 
structures are physiologically involved in the process.
This behavioral effect suggests an important central action 
of these peptides.
DeWied, in a later study substantiated the inhibitory 
effect of ACTH and related peptides on extinction of condi­
tioned avoidance behavior (1966). In that study, rats were 
trained on an active avoidance response which was performed 
in either a shuttle box or a pole jumping situation and
18
injected with either ACTH, synthetic ACTH-1-24, ot-MSH, /-POSH, 
ACTH-1-10, ACTH-5-10 or ACTH 11-24. All injections were ad­
ministered during extinction. It appeared that ACTH and 
related peptides significantly delayed the rate of extinction 
of the avoidance response, with full activity being obtained 
with ACTH-1-10 peptide while ACTH-5-10 was less active. ACTH- 
11-24 was without effect. DeWied concluded that the active 
part of ACTH in this respect is located in the first 10 amino 
acids.
Support for this conclusion was given by DeWied and 
Piere (1968) who studied the inhibitory effect of ACTH-1-10 
on extinction of a conditioned avoidance response (CAR). In 
that study, the ACTH analogue ACTH-1-10 was studied on the 
rate of extinction of a pole jumping active avoidance response 
in thyroidectomized rats with and without replacement therapy 
of thyroxin. ACTH-1-10 appeared to delay the rate of extinc­
tion of the CAR in thyroidectomized rats and was also active 
in thyroidectomized rats ttreated with thyroxin. The thyrox­
in treatment itself also caused a significant delay in the 
rate of extinction of the CAR, a finding which indicated that 
the inhibitory effect of ACTH-1-10 on the rate of extinction 
of a CAR is not mediated by the thyroid gland.
In a recent article, Stephen B. Klein (1972) attempt­
ed to investigate the role of ACTH in the retrieval of the 
memory of an acquired avoidance in rats. The research of
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DeWied and his associates (e.g. Bohus, 1968, 1970,* Bohus and 
DeWied, 1966; DeWied, 1965* 1966, 1967; DeWied and Bohus,
1966; and Greven and DeWied, 1967) indicates that the admin­
istration of ACTH or structurally related polypeptides after 
avoidance training elevates responding during extinction 
above normally observed values, while corticosterone or 
similar steroid hormones have been found to facilitate the 
extinction of avoidance behavior when administered after 
acquisition training. In terms of a memory retrieval frame­
work, ACTH causes a rat to continue to respond during extinc­
tion as the result of the maintenance of the internal stimulus 
state associated with avoidance acquisition, whereas the 
presence of corticosterone changes the stimulus context at 
testing which prevents the retrieval of the avoidance behavior 
and facilitates its extinction. In addition, Klein showed 
reinstatement of the avoidance-learning memory at Intermedi­
ate retention intervals with either water stress, lateral 
anterior hypothalamic stimulation or direct Implantation of 
ACTH into the lateral anterior hypothalamus. According to 
Klein, these experimental treatments allowed animals to re­
spond according to prior avoidance training at the intermedi­
ate interval retention test. It was concluded that ACTH is 
capable of facilitating the retrieval of the memory of prior 
avoidance training by returning the animal to the same in­
ternal state as when learning occurred. This presumably CNS
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effect of ACTH has been reported by other Investigators as 
well.
For example Wimersma Greidanus and DeWied (1971) 
studied the effects of systematic and intracerebral admini­
stration of two opposite acting ACTH related peptides on the 
extinction of a pole jumping CAR in rats. They found that 
ACTH-1-10 in doses of 20, 50, and 100 pg Inhibited extinction 
of the response 4 hours following subcutaneous administration. 
Similarly, intracerebral implantation of approximately lOpg 
of the ACTH analogue in freely moving rats had similar effects 
on extinction when implanted into the region of the rostral 
mesencephalon and caudal diencephalon, at the posterior tha­
lamic level or in the cerebrospinal fluid. Ineffective sites 
were the nucleus ventralis thalami, the nucleus anterior 
medialis thalami, the nucleus reuniens, the globus pallidus, 
the nucleus accumbens, the fornix, and the hippocampus. The 
results support the hypothesis that the site of action of 
ACTH and of ACTH analogues on extinction of an active avoid* 
ance response is localized ihethe CNS.
Similarly, Ferrari et al. (1963) have found that in­
jection of MSH or ACTH into the cisterna magna of dogs pro­
duces muscular hypertonus evidenced by a stretbhing response. 
This stretching syndrome was found also in rabbits, cats and 
rats. The authors suggested that the many symptoms of the 
syndrome (apathy, muscular tremors, drowsiness, and yawning)
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were exaggerations of physiological functions and a few work­
ing hypotheses were suggested. While several authors have 
described extra-corticotropic actions of ACTH (DeSalva, 195^; 
Engel and Engel, 1958), including neurotropic actions (Torda 
and Wolff, 1952; Baruk, Rougerie, Racine and Vallancien, 1952; 
Monnier, 1953; Zapadnyuk, 1958; and Herz, Krupp and Monnier, 
1961) many considerations suggest a neurohormonal role for 
MSH peptides. Among these are: (a) melanophores are de­
rived from the neural crest (Krivoy and Guillemin, 1961),
(b) the hypothalamus of hypophysectomized rats takes up se­
lectively Injected MSH, (c) the CNS and particularly the 
hypothalamus contain materials with MSH activity (Long,
Krivoy and Guillemin, 1961), (d) Krivoy and Guillemin show 
that A-MSH potentiates submaximal evoked potentials in the 
cat spinal cord (1961).
As Abba Kastin has pdinted out, work on the behavioral 
aspects of MSH has been confined primarily to two groups 
studying similar problems from different points of view 
(Kastin, Miller, Nockton, Sandman, Schally and Stratton, 1972). 
DeWied and his collaborators (see above) have pioneered this 
field with their major emphasis upon ACTH and viewing MSH 
as an "ACTH-like peptide" (DeWied and Bohus, 1961). Kastin, 
on the other hand, has focused his interest upon MSH itself, 
in that MSH and ACTH are structurally similar, and since 
much of the work on ACTH and its analogues probably applies
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to our understanding of the actions of MSH, much of the pre- 
ceeding material has dealt with ACTH. The remainder of this 
review, however, will be restricted primarily to a discussion 
of MSH and a substance presumed to control its release, MIP 
(MSH-inhibiting factor).
Throughout the literature, the extra-pigmentary effect 
of MSH and related peptides has been restricted to condition­
ed avoidance responses, and little attention has been given 
to other types of behavior as well. With this in mind, 
Sandman, Kastin and Schally (1969) studied the effect of MSH 
on animals tested in an appetitive task. In this study, 
hungry rats were trained to run to an arm of a T-maze which 
contained food. With subsequent removal of the food, rats 
receiving MSH continued to run faster and more often to the 
goal box which had previously contained the food as 'compared 
with rats injected with control solutions. Prom this study, 
it appeared that MSH affected behavior in more than one type 
of situation, with this affect involving the perseverance of 
an active approach response. Although Dempsey (unpublished 
data) found no differences between MSH and control animals 
on extinction of a bar pressing task for positive reinforce­
ment, Kastin, LeBlanc, Miller, Schally and Miller (1972c) 
report such differences. The discrepancy in this data is 
not yet accounted for.
The data also Indicates that once a rat treated with
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exogenous MSH has learned a simple task, such as avoiding 
shock (DeWied, 1965)t obtaining food when hungry by running 
(Sandman et al., 1969) or pressing a lever (Kastin et al.,
1972), it continues to make that response even when it is no 
longer rewarded (Kastin, personal communication). Perhaps 
it is possible to speculate that this behavior is analogous 
to pigmentary effects such as the darkening of a frog by 
endogenous MSH when it is on a dark background. Accordingly, 
the frog escapes danger by this camouflage, but the darkening 
may be unrelated to the presence of danger since it can per­
sist unrewarded even in the absence of a predator. This 
behavior can be construed as being adaptive in a simple situa 
tion even though it may not always be purposeful (Kastin, 
personal communication).
The question arises, however, as to whether increased 
resistance to extinction is an adaptive response. In the 
case of the lever-pressing response for food, for example, 
regardless of the number of responses made during extinction, 
none are rewarded. Yet such MSH animals continue to respond 
as though some type of hyper-activity or perseveration is 
taking place.
In an attempt to test this hypothesis, Sandman, Kastin 
and Schally (1971a) tested the performance of rats on a re­
versal discrimination task. In this study, rats were trained 
to escape shock by running to an illuminated door of a Y-maze
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When the task was learned (five out of six correct trials 
for two successive days), the task was reversed so that escape 
from shock only occurred by running to the arm of the Y-maze 
in which the door was not illuminated. If MSH did produce a 
perseverating response, than animals treated with the hor­
mone would take longer to reverse. When tested under condi­
tions of constant illumination, Which presumably decreases 
endogenous release of MSH (Kastin, 1967a), rats injected with 
MSH reversed faster than the animals injected with control 
solution. This finding would not be expected if MSH only 
caused perseveration of activity in this relatively simple 
task and does indicate an adaptiveness on the part of MSH 
animals. But this task like the ones above involved the 
animal in some form of activity, generally in the category of 
motoric behavior.
Although certain effects of MSH have been reported, 
one might ask whether this is a specific effect or merely a 
reflection of increased general activity. Kastin et al. (1972b) 
specifically measured activity after injection of MSH in uns 
stimulated Intact and hypophysectomized rats, but failed to 
find any significant differences. They did, however, report 
tremendous individual variation. Preliminary results with 
goldfish indicate that intracranial injection of MSH does 
cause hyperactivity (Bryant, Petty and Kastin, 1972). On 
the basis of the available data, it seems unlikely that an
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effect of MSH upon the level of general activity in the rat 
could fully explain its effects upon behavior.
Among the alternatives available, careful considera­
tion must be given to the possibility that MSH increases the 
general emotional state of arousal in the rat. The interac­
tion of emotional state with learning after administration of 
MSH was investigated in a dual chamber shuttle box (Kastin, 
Nockton, Schally and Elder, 1972d). Using a within-subjects 
design, active and passive avoidance responses were combined 
with high and low levels of shock. It was reasoned that if 
fear motivation were involved in the effect of MSH on a rat's 
learning to avoid shock, then the action of MSH should be 
greater at the higher levels of shock. Contrary to what would 
be expected, rats receiving MSH made fewer total responses 
at the higher level of shock, but their percentage of correct 
responses was significantly greater. Since the basis of re­
sponding in this experiment rested on visual cues, the results 
also indicated that MSH could increase attention under condi­
tions of high emotional arousal. Again, the behavioral 
effect of MSH in the rat could be interpreted as being adap­
tive .
Other evidence suggesting an effect of MSH upon atten­
tion was reported in human beings (Kastin et al., 1971a).
In that study, tests of visual and verbal retention were per­
formed in five subjects who received synthetic oC-MSH. A
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significant improvement in the Benton Visual Retention Test 
occurred after the infusion of MSH, but no improvement in 
verbal retention was noted. In that same study, measure­
ments of the amplitude of electric responses evoked in the 
human brain by threshold electric stimulation of the median 
nerve were recorded. Administration of MSH caused a signifi­
cant increase in the averaged somatosensory evoked responses 
when the subjects were relaxed; this increase became strik­
ingly greater when the subjects paid particular attention to 
the sensory stimulation.
The first effects of MSH upon electircal activity of 
the human brain were shown several years ago (Kastin et al., 
1968). Similar high voltage, intermediate frequency activity 
and disintergration of alpha activity has been reported in 
rabbits (Dyster-Aas and Krakau, 1965), rats (Sandman et al., 
1971b)> and frogs (Denman et al., 1972). The pattern of the 
EEG in the rat after injection of MSH resembled limbic system 
electrical activity.
In reviewing the literature, one sees one consistency 
throughout all the studies and that is that they all involve 
or require the animal to make some type of response (i.e., 
active avoidance) and even when a passive avoidance response 
is employed, the animal still has an opportunity to remain 
active. For example, Sandman et al., (1971a) tested the 
effects of MSH on a passive avoidance situation in order to
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determine if indeed MSH animals were "hyperactive" and unable 
to inhibit a response tendency. In that study, rats were 
placed in one chamber of a two chamber apparatus and the time 
it took for them to enter the second chamber was recorded.
As soon as the rat entered the second chamber, electrical 
shock was administered. After two days, the rats were placed 
in the first chamber again. If the main effect of MSH was to 
cause perseveration of behavior, it would be expected that 
the rats injected with MSH would not take any long&ri'than the 
control rats to enter -the chamber in which they had been 
previously shocked. Results showed, however, that under cer­
tain lighting conditions, MSH animals took about three times 
longer to enter the second chamber than the rats injected 
with control solutions. Sandman et al. concluded that ani­
mals injected with MSH were clearly able to inhibit a passive 
avoidance response (PAR) since if MSH did have a disinhibit- 
ihg effect, which might be evidenced through increased acti­
vity, then those animals receiving the hormone would not be 
able to remain passive. But since a two-chambered apparatus 
was employed, it may have been possible for the MSH animals 
to be active only in the "safe" chamber and yet still be 
considered "passive" because they; did not enter the second 
chamber. In this investigation, albino rats were injected 
during acquisition as well as extinction.
Recently attention has been given to a substance that
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is thought to control the endogenous release of MSH. This 
substance is known MIF. This hypothalamic hormone, in addi­
tion to regulating MSH release, has recently been shown to 
potentiate the effects of DOPA both in normal and hypophy^ 
sectomized mice (Plotnikoff, Kastin, Anderson and Schally, 
1971) In that report, it was extablished that MIF exerts 
an action upon the CNS that is independent of its MSH inhibit­
ing activity. This was the first "extrapituitary" effect to 
be shown for any hypothalamic hormone and its potential use 
for such conditions as Parkinson's syndrome were certainly 
indicated. Consequently, much of the limited research with 
MIF has focused on this aspect.
For example the effects of tremorine in inducing tremor 
in animals were originally described by Everett(1956). Sub­
sequently, oxotremorine was shown to be the active metabolite 
responsible for these actions and has been widely used to 
investigate drugs for treatment of Parkinson's disease. In 
that DOPA has been shown by Everett to antagonize the tremors 
caused by oxotremorine (Everett, Morse and Borcherding, 1971) 
and since MIF potentiates some CNS effects of DOPA, studies 
have been conducted to investigate the effects of MIF on tre­
mors in mice (Plotnikoff, Kastin, Anderson and Schally, 1972). 
These investigators demonstrated antagonistic effects of MIF 
on both central and peripheral effects of oxotremorine in 
normal as well as in hypophysectomized mice.
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In view of the possibility that MIF might be useful 
in the treatment of parkinson's disease, clinical studies to 
investigate possible significant actions in man, particularly 
upon extrapyramidal symptoms and signs, have recently been 
conducted (Kastin and Barbeau, 1972). These investigators, 
using 16 parkinsonian patients, concluded that intravenous 
or oral administration of MIF appears to be a safe procedure 
in human subjects and possesses some antiparkinsonian activi­
ty. Perhaps most significant was the finding that MIF, if 
used with levadopa, can reduce some of the drug-induced dys­
kinesias associated with levadopa treatment.
One may still be inclined to ask about the relevance 
of such "psycho-endocrine" research in general and MSH/MIF 
research in particular for the science of psychology. To date,
only a few sex hormones and one pituitary hormone have so far
been experimentally linked with specific behavioral phenomena. 
The one pituitary hormone is ACTH, and most intriguingly ACTH 
is not only sturcturally related to MSH, but it also has some 
MSH-like activity. So research such as contained in the pre­
sent paper is in part designed to substantiate the possibili­
ty that another pituitary: hormone, MSH, may indeed have di­
rect behavioral consequences.
But what is the nature of such behavioral consequences? 
that are presumably induced by MSH? Such areas as learning,
motivation, and memory seem in part to be the answer.
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Although the data is far from conclusive there are definite 
indications that MSH may facilitate the acquisition of particu­
lar active avoidance responses. Surely such findings have 
direct relevance for psychology in general and for clinical 
psychology in particular, especially if they can be further 
substantiated and extended. Indeed it suggests possible 
application to children with problems of attention. In 
addition, there is some evidence that MSH may inhance motiva­
tional states, as suggested by its inhibitory effect on ex­
tinction. This finding is not too surprising if one realizes 
that the release of MSH is directly controlled by the hypo­
thalamus, a structure which already has been shown to have 
devastating motivational effects when either lesioned or 
stimulated (see Hetherington and Ranson, 19^2). Kastin has 
shown that one of the chemicals released from the human hypo­
thalamus is MIF. Only one other hypothalamic factor to date 
has been definitely shown to be an inhibitor of a pituitary 
hormone; the other hypothalamic factors stimulate pituitary 
hormones. There is also evidence to suggest that MSH improves 
performance under various motivational states (especially 
stress), a finding that conceivably could have a profound 
influence on psychology.
But most important, and perhaps staggering is the 
effect that MSH seems to have on memory facilitation and re­
tention. Although the data is far from conclusive, there is
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evidence for example, that MSH Injections help human subjects 
perceive and reproduce from memory certain goemetric forms 
(Kastin et al., 1971a)- But more recently, there has been 
evidence to suggest that MSH may contain a chain of amino 
acids in a sequence which some investigators suggest is the 
biochemical basis of memory. Working with rat brains, 
scientists at the Baylor College of Medicine have reported 
that memory (in this case of an electric bell and its conse­
quences) is stored in an eight-segment chain of six specific 
amino acids, the basic chemicals of life (Ungar and Bunzynsky,
1973)-
In light of those findings and implications, it would 
seem that the importance of MSH and MIP for psychology as well 
as for other scientific disciplines may be of staggering di­
mensions. What seems to be necessary now is for more basic 
research with the two hormones to be condicted and extended. 
For it will only be through such research that the effects 
of both MSH and MIP can be fully ascertained.
For these reasons, Experiment I was designed to test 
the effects of MSH and MIP on the acquisition and retention 
of a highly restricted passive avoidance response that 
required pigmented (hooded) rats injected at varying times 
to remain largely inactive in order to avoid a mild electri­
cal shock. To insure that the response would be "restric­
tive," a step-down platform of small dimensions was employed.
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Also to ascertain the possible effects oil both the acquisi­
tion and retention of the task, only one learning trial was 
given. Finally, to determine if either quantity of MSH or 
MIF or time of injection was important, the solutions were 
administered in what eventually amounted to varying quantities 
and times of injection. Since the results of a pilot showed 
lighting to be a significant factor, the experiment was run 
under constant illumination.
Experiment II was performed to establish future guide­
lines for dosages of both MSH and MIF as they pertain to 
behavioral responses. In the past, dose response curves 
have been established for these hormones based on a pigmen­
tary change, a physiological measure obtained by first in­
jecting animals with either MSH or MIF and noting any pig­
mentary change. This study attempts to define a dose response 
relationship for both hormones usihg a behavioral response 
(step-down latency).
METHOD 
Experiment I
Subjects
The subjects consisted of 5^  male, hooded rats 
(Simonsen) weighing l60-l80g at the beginning of the study.
Apparatus
A Lafayette Instrument Company operant chamber was 
used. At one end of the chamber, a 2.5cro high step-down 
platform, 15cm long and 10cm wide was mounted to the grid 
floor. A guillotine door separated the platform from the 
rest of the chamber.
Procedure
The rats were randomly assigned to one of nine coded 
treatment groups and housed in pairs under conditions of con­
stant light. A 3-day adaptation period was allowed for the 
rats to adjust to the lighting conditions before acquisition 
training began. Based on the results of a pilot study, it 
was determined that one trial was sufficient for acquisition 
to occur. Therefore, after intraperitonea 1 injections of 
synthetic 0(-MSH (lOug/rat), synthetic L-Pro-L-Leu-Gly-NH2 
(0.5mg/rat) (an MIF), or the diluent (0.01M acetic acid in 
0.9$ saline) as a control solution, all animals were placed
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on the step-down platform. The guillotine door was raised 
and when the rat had stepped off the platform (all four feet 
on the grid floor) a mild electric shock was administered for 
2 sec. Acquisition consisted of only this one trial. For 
the next 2 days, all animals received daily injections but 
were not returned to the apparatus. On the fourth day, all 
rats underwent extinction, which consisted of returning the 
rat to the platform and recording the step-down latency.
MSH and MIF were administered as coded solutions whose 
contents were unknown to the experimenter in the following 
arrangement: on acquisition day only, on extinction day only,
on both acquisition day and extinction day, or on all 4 days. 
On the days when MSH or MIF were not scheduled, animals re­
ceived injections of the diluent. The treatment groups are 
as follows:
Acquisition only--the subjects in this group received 
either MSH or MIF fifteen minutes before acquisition training. 
For the following three days, these animals received injec­
tions of the control solution.
Extinction only--the subjects in this group were in­
jected with either MSH or MIF fifteen minutes before the ex­
tinction session. During acquisition and the two day delay 
period, these subjects received injections of the control 
solution.
Acquisition plus Extinction only— subjects in this
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group were administered injections of MSH or MIP on both 
acquisition day and extinction day. During the two day delay 
period, these subjects received the control solution.
Continuous— animals in this group received injections 
of MSH, MIP or the diluent on all four days.
The design thus consisted of a 2 x 4  factorial arrange­
ment of treatments Incorporating solution and treatment 
period, plus a control group. All animals were tested ap­
proximately 15 minutes after intraperitoneal injections and 
maintained on ad lib food and water throughout the experiment.
RESULTS
The step-down latency during extinction was recorded 
for each rat and subjected to an analysis of variance. Re­
sults showed the main effect of solution to be significant 
(F» 23.61, p< 0.001) indicating that, overall, MSH animals 
inhibited significantly longer than rats injected with MIF 
or diluent. There was, however, no significant difference 
between animals receiving MIF and the control group (p>.05). 
The main effect of the treatment period was also not signi­
ficant (p>.05) indicating that regardless of when MSH was 
administered, it produced increased inhibitory performance. 
Additional specific statistical comparisons (t-tests) showed 
that within the MSH group there were no significant differen­
ces suggesting that all animals injected with MSH inhibited 
equally well. Similarly, group comparisons within the MIF ; 
group Indicated no significant differences, indicating their 
performance to be essentially the same as that of the control 
animals.
Additional statistical analysis consisting of compari­
sons between MSH and MIF groups during all  ^injection periods 
showed that in each case, MSH animals had significantly, longer 
step-down latencies thah MIF animals. This was the case 
whether the solutions were injected during acquisition only,
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during extinction only, during both acquisition and extinction 
or during all 4 days.(see Table l).
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TABLE 1
MEAN STEP-DOWN LATENCIES 
DURING EXTINCTION (sec)
Solution
Acq. Ext.
Group
Acq. and Ext. All
MSH 167.7 147.5 214.2 150.3
MIP 8 2 . 2 18.3 23.5 47.3
Control - - - 50.8
DISCUSSION
The finding that administration of MSH resulted in in­
creased resistance to extinction of a PAR in hooded rats sup­
ports earlier findings with albino rats (Sandman et al., 
1971a). In the present study, however, the animals were re- 
wuired to remain almost totally passive or inactive to suc­
cessfully inhibit a response. This finding fails to support 
any disinhibiting effect of MSH. Instead, It appears that 
MSH may have a general facilitative or adaptive function, 
enabling the animal to respond In the most beneficial manner. 
The rats were exposed to constant illumination in an attempt 
to reduce endogenous levels of MSH (Kastin, Schally, Viosca, 
Barrett, and Redding, 1967) and hence magnify the effects of 
the exogneous MSH injected intraperitoneally. The reason for 
the effectiveness of this procedure in the present study as 
opposed to previous ones is not known.
A critical finding of this study was the fact that 
MSH resulted in increased inhibitory performance regardless 
of when it was administered. Animals receiving their first 
injection of MSH 15 minutes before extinction, for example, 
inhibited equally as well as any other MSH group. The im­
portant aspect appears not to be the time of injection, nor 
the cumulative dose for 1-4 days, but simply whether or not
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the rat was injected with MSH.
These results are compatible with the suggestion (dis­
cussed by Kastin et al., 1973) that MSH may increase the 
emotional state of the animal at least in simple tasks. Al­
though the mechanism for this function is not known, recent 
electroencephalographic data suggest that the limbic system, 
specifically/the hippocampus, may discharge after injection 
of MSH (Sandman, Miller, Kastin and Schally, 1973). It also 
has been suggested on the basis of information obtained in a 
study with human beings, that MSH may be involved in the pro­
cess of attention or visual retention (Kastin et al., 1971).
It seems possible, therefore, that MSH may alter the emotional 
state of the organism resulting in increased sensitivity or 
attention to aversive stimuli in simple situations. Indeed, 
it may be that MSH potentiates a hightened emotional state 
characterized by an increased fear response. When MSH ani­
mals are returned to the step-down platform on test day, for 
example, they typically crouch on the platform, defecate and 
urinate, and usually remain quite stationary. This behavior 
may be due to an increase in "retention" of the aversive 
stimulation (footshock) received earlier in the chamber and 
it may also indicate a facilitation of the attentions! system. 
To specify the mechanism of action induced by MSH at this 
time, however, would be mere speculation. Regardless of the 
interpretation, MSH was found to influence the inhibitory
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performance required In a highly restricted PAR.
A perhaps puzzling finding of this study was that no 
MIP groups differed significantly from the control group.
If MIF actually Inhibits the release of pituitary MSH, and 
if MSH in any way Is responsible for an inhibition of the 
step-down response, then it might be predicted that MIF ani* 
mals would step off the platform sooner than MSH animals 
(an observed finding) and logically even sooner than control 
animals sense control animals presumably have a greater en­
dogenous level of MSH than MIF animals. This finding was 
not obtained. Table 1 shows that the mean latencies for the 
MIF groups were lower than the control group (but not signifi­
cantly) in each group except when it was injected on acquisi­
tion day only. This suggests that MIF must be administered 
on test day (day 4) if the predicted result is to be obtained. 
But these results were only in the trend of the prediction 
and there were no significant differences between any of the 
MIF groups and the control group.
Three possible explanations may account for this find­
ing. First, MIF may, despite previous claims, have no be­
havioral effects. Secondly, the dosage was insufficient to 
detect any behavioral differences. Or thirdly, the experi­
mental paradigm may not have been sensitive enough to detect 
differences in the opposite direction of MSH (i.e. a possible 
inverted ceiling effect). Of these explanations, the first
^2
two seem more tenable.
For this apparent contradictory finding a second experi­
ment was performed which attempted to vary doses of MSH and 
MIF and to measure any differential effects on the same 
behavioral task as that used in Experiment I. This study 
would then serve as a partial replication of the present 
study and as an extention of the available literature con­
cerning MSH and MIF dosages and their respective behavioral 
consequences.
METHOD 
Experiment II
Subjects
The subjects were 66 male, hooded rats (Simonsen) 
weighing 190-280g at the beginning of the experiment.
Apparatus
The apparatus was identical to that employed in 
Experiment I.
Procedure
The rats were randomly assigned to one of 11 coded 
treatment groups, and housed individually under conditions 
of constant illumination. A three day adaptation period was 
allowed for the animals to adjust to the lighting conditions 
before acquisition training began. During this time, each 
subject was handled daily for five minutes. On the fourth 
day, all animals were weighed and injected with a coded solu­
tion. Fifteen minutes after the injection, all animals were 
placed on the step-down platform. The guillotine door was 
then raised and when the animal had stepped off the platform 
(all four feet on the grid floor), a 6ma footshock of 2 sec 
duration was administered. Following this initial trial, 
the animals were removed from the aparatus and returned to
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their home cages where they remained on ad lib food and 
water for the next 2 days. During this 2 day delay period, 
animals were weighed and given daily injections but were not 
returned to the step-down platform. On day 7> all rats were 
again weighed, injected and returned to the platform where 
their step-down latencies were recorded.
MSH and MIF and the control solution were administered 
daily for 4 days in coded solutions whose contents were un­
known to the experimenter. These 11 solutions and their re­
spective dosages are as follows: MSH (u/kg body weight)--
20, 40, 80, 160, and 320. MIF (mg/kg body weight)— 1, 2, 4,
8, 16. Control solution (mg/kg body weight)--l.
Thus the design was a completely randomized design 
consisting of 10 treatment groups and a single control group. 
All animals were tested approximately 15 min after intraperi- 
toneal injections and maintained on ad lib food and water 
throughout the experiment. The study was run under conditions 
of constant illumination.
RESULTS
The step-down latencies were recorded for each rat 
and subjected to an analysis of variance. Results showed 
a significant treatment effect (F»7.39j p<.Ol) indicating 
that overall, there was a significant difference in the 11 
groups (see Table 2). To determine how the MSH and MIP 
groups differed from the control group, Dunette's t values 
were calculated. Results of this statistical analysis show­
ed the following groups to have significantly longer step- 
down latencies than the control group (p<.Ol): MSH 20u/kg,
MSH ^Op/kg, MSH 80p/kg, MIP Img/kg, and MIF 8mg/kg. All 
other pair-wise comparisons between the treatment groups 
and the control group were not statistically significant 
(see Figure 1).
^5
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TABLE 2
MEAN STEP-DOWN LATENCIES 
DURING EXTINCTION (sec)
Solution Dosage
MSH 20 40 80 160 320
U A s )
138.3204.5 205.3 190.5 20.0
MIP 1 2 4 8 16
(mg/kg)
Control
(mg/kg)
244.2
_1
43.0
37.33 125.5 237.7 68.7
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(sec)
FIGURE 1
MEAN STEP-DOWN LATENCIES AS A 
FUNCTION OF DOSE LEVEL
275
225
175
125
1 2  4 1640 80 160 C
MSH MIF
(u/kg) (mg/kg)
DISCUSSION
Perhaps the most significant finding of this study is 
the fact that as MSH dosages increased, its behavioral effect 
(in this case, step-down latency) decreased. This result, 
however, did not occur until somewhere between the dosages 
of 80 and 160 1^/kg body weight. Also this effect is even 
more dramatic at the 3Q0ji,kg dose. To what may this effect 
be attributed?
Perhaps if a memory or attention hypothesis is em­
ployed, massive doses of MSH function to impair attention or 
memory retention. Indeed the latencies for the largest MSH 
dose could be construed to represent an amnestic effect.
Such animals' step-down latencies were below-(but not signi­
ficantly) the control group. This type of explanation appears 
tenuous at best in that It can first of all be argued that 
those animals stepping off the platform the quickest are 
actually making a more adaptive response (remember that 
footshock Is not present on test day). Secondly, it may be 
that large doses of MSH have little to do with memory or its 
processes but instead, may function to reduce Intrinsic fear 
levels. How this may occur, however, Is yet to be determined.
This finding also seems to explain an apparent contra­
diction in the literature which centers on reports that MSH
48
4 9
injections produce both drowsiness (Sakamoto, 1966 and Ferarri, 
1963) and hyperactivity (Sandman et al., 1969). In such a 
framework, the data suggest that at small to moderate dose 
levels, MSH may produce an effect characterized by drowsi­
ness (although the author made no such observations during 
the course of either study) and at large to massive dosages,
MSH may produce a generalized hyperactivity. This would 
account for the inverse relationship between MSH dosage and 
step-down latency. Finally the MSH 20p/kg group was essen­
tially the same dosage as that employed in experiment I and 
the stem-down latencies for these two MSH groups were com­
parable, thus replicating that aspect of the first experiment.
There was no consistent pattern of responding for the 
5 MIF groups in this experiment, but despite the rather abrupt 
fluctuations between the groups, the MIF 2mg/kg group, which 
approximated the MIF dosage used in Experiment I, had compar­
able mean step-down latencies to those obtained in Experiment 
I. Again the first study had been in part replicated.
Because of the apparant chance fluctuation within the 
MIF groups, it is difficult, perhaps impossible at this time 
to speculate on the results obtained with this solution.
The author feels hardpressed to account for the MIF data at 
this time but does, however, plan to replicate this portion 
of Experiment II at a later date.
CONCLUSIONS AND SUGGESTIONS 
FOR FURTHER RESEARCH
In reviewing these findings in terms of furture specu­
lations it can be said first of all that MSH does indeed 
appear to have direct behavioral consequences. While results 
with MIF appear much more variable, its relationship to and 
possible treatment for Parkinson's disease certainly dictate 
additional psychoendocrine study for both hormones. Aside 
from this, what may be the outcome of subsequent research in­
volving these hormones and how might these be a part of the 
science of psychology?
If one were inclined to reason teleologically, one 
might interpret the many mechanisms which control the release 
of MSH as being evidence for its importance. These mechanisms 
have been reviewed elsewhere (Kastin and Schally., 1971) and 
include the pineal, light and dark, stress, various drugs 
like phenothiszines and morphine, possibly a hypothalamic 
substance stimulating MSH release, and perhaps most important­
ly, a hypothalamic inhibitor of MSH named MIF.
But more logically speaking, MSH is a hormone whose 
presence has persisted in the pituitary gland of vertebrates 
from very low forms to man. Although the primary function 
of MSH in higher mammals no longer appears to be pigmentary,
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this is not sufficient reason to assume that MSH has no role 
in mammals and is merely a vestigial predecessor of ACTH.
Although it cannot yet be definitely synthesized into 
a single unifying hypothesis, the data presented in this 
dissertation seem to have relevance to such psychological 
constructs as attention, memory, emotional arousal, motiva­
tional states, and perhaps learning. Obviously what is most 
needed is additional research with these two hormones. In 
addition to replicating the MIP section of Experiment II 
the author is in the process of planning several research 
projects involving both MSH and MIP.
One such project involves the use of animals lesioned 
in either the substantia nigra or subthalamic area. It is 
a well established finding that such animals exihibit tremenH 
dous losses on a passive avoidance task. The purpose of this 
study would be to determine whether or not either MSH or MIF 
could "restore"such losses. A secondary purpose would be 
to investigate the effects of MIF on induced-tremors that 
typically follow substantia nigra lesions. In effect, this 
would be an extension of the MIP research on Parkinson's 
disease.
Another research problem centers on the possible 
effects of MSH and MIP on the attention process. Results of 
previous studies have indicated an Inhancement of attention 
following administration of MSH but these studies have dealt
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with sighted animals. In this proposed study, blinded 
animals will be used and instead of visual feedback, a task 
involving kinesthetic feedback will be employed. This will 
be accomplished by using an elevated T-maze apparatus.
Finally, the author plans to explore the effects of 
both hormones on various motivational states and how they 
affect a variety of instrumental responses. One of these 
responses will simply be runway speed in mild, moderate and 
severely deprived (food) subjects.
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